angioplasty

(redirected from Transluminal coronary angioplasty)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.
Related to Transluminal coronary angioplasty: Percutaneous Transluminal Angioplasty

angioplasty

(ăn`jēōplăs'tē), any surgical repair of a blood vessel, especially balloon angioplasty or percutaneous transluminal coronary angioplasty, a treatment of coronary artery diseasecoronary artery disease,
condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. Coronary artery disease is the most common underlying cause of cardiovascular disability and death.
..... Click the link for more information.
. In balloon angioplasty a balloon-tipped catheter is inserted through the skin into a blood vessel and maneuvered to the clogged portion of the artery. There it is threaded into the blockage and inflated, compressing the plaque against the arterial walls. Frequent postoperative reclogging (restenosis) of the treated area has led to the use of alternative techniques such as laser angioplasty, which employs a laser to burn away or vaporize the plaque, and to the study of various drugs, gene therapies, and mechanical devices such as a stainless steel coil, or stent (most often now coated with a drug that inhibits restenosis), designed to hold the plaque back.

angioplasty

[′an·jē·ə‚plas·tē]
(medicine)
A procedure for alleviating blockage of an artery in which a balloon-tipped catheter is threaded into an artery to a point of obstruction and inflated to push the vessel open.
References in periodicals archive ?
* Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters under development
Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up.
The aim of the present study was to observe the feasibility of drug coating on percutaneous transluminal coronary angioplasty (PTCA) balloon catheter by dip coating technique and analyze the in-vitro release pattern of Sirolimus on inflation.
New electrocardiographic criteria for posterior wall acute myocardial ischermia validated by a pereutaneous transluminal coronary angioplasty model of acute myocardial infarction.
On April 18, 1997, a transluminal coronary angioplasty and stenting procedure was performed.
ANGIOMAX is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
Coronary dilatation catheters are used to open blocked coronary vessels during percutaneous transluminal coronary angioplasty (PTCA), which is a significant alternative to coronary bypass surgery in specific patient types.
The procedures include but are not limited to coronary bypass surgery, percutaneous transluminal coronary angioplasty, and medical (drug) treatment.
Nonsurgical revascularization of the heart became possible in 1977 with the introduction of percutaneous transluminal coronary angioplasty (PTCA) (Balm, 1993).
Invasive techniques that improve the blood supply to the heart may be used, such as percutaneous transluminal coronary angioplasty (PTCA), also known as angioplasty or balloon angioplasty, and coronary artery bypass graft surgery.
(15) James Cameron et al., Outcome Five Years After Percutaneous Transluminal Coronary Angioplasty or Coronary Artery Bypass Grafting for Significant Narrowing Limited to Left Anterior Descending Coronary Artery, 74 AM.
The effectiveness of invasive cardiovascular procedures, including percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG), and their contribution to the observed decline in mortality rates from ischemic heart disease, have been the subject of debate (Goldman and Cook 1986, Killip 1986).